These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3293084)

  • 21. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.
    Xagorari A; Papapetropoulos A; Mauromatis A; Economou M; Fotsis T; Roussos C
    J Pharmacol Exp Ther; 2001 Jan; 296(1):181-7. PubMed ID: 11123379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide.
    Calkins CM; Heimbach JK; Bensard DD; Song Y; Raeburn CD; Meng X; McIntyre RC
    J Surg Res; 2001 Dec; 101(2):232-7. PubMed ID: 11735280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves.
    Adams JL; Semrad SD; Czuprynski CJ
    J Clin Microbiol; 1990 May; 28(5):998-1001. PubMed ID: 2112564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor mediates endotoxic effects in mice.
    Bauss F; Dröge W; Männel DN
    Infect Immun; 1987 Jul; 55(7):1622-5. PubMed ID: 3596805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the tumor necrosis factor in the pathogenesis of infectious-inflammatory endotoxicosis].
    Povzun SA
    Vestn Khir Im I I Grek; 1991; 147(7-8):127-32. PubMed ID: 1668919
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of bacteria/endotoxin translocation in the development of multiple organ failure.
    Bahrami S; Redl H; Yao YM; Schlag G
    Curr Top Microbiol Immunol; 1996; 216():239-58. PubMed ID: 8791743
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of augmentation of endotoxin fever by beta interferon in rabbits: possible participation of tumor necrosis factor (cachectin).
    Kawasaki H; Moriyama M; Nariuchi H
    Infect Immun; 1992 Mar; 60(3):933-6. PubMed ID: 1541566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor.
    Bartholeyns J; Freudenberg M; Galanos C
    Infect Immun; 1987 Sep; 55(9):2230-3. PubMed ID: 3623699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science, 1985, 229(4716):869-871. Classical article.
    Beutler B; Milsark IW; Cerami AC
    J Immunol; 2008 Jul; 181(1):7-9. PubMed ID: 18566363
    [No Abstract]   [Full Text] [Related]  

  • 31. Endotoxin modulation: metabolism to monoclonals.
    Napolitano LM; Boyd JL; Stanford GG; Chernow B
    Prog Clin Biol Res; 1989; 299():115-21. PubMed ID: 2498906
    [No Abstract]   [Full Text] [Related]  

  • 32. Shock and tissue injury induced by recombinant human cachectin.
    Tracey KJ; Beutler B; Lowry SF; Merryweather J; Wolpe S; Milsark IW; Hariri RJ; Fahey TJ; Zentella A; Albert JD
    Science; 1986 Oct; 234(4775):470-4. PubMed ID: 3764421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical, physiological and clinical aspects of endotoxemia.
    Olson NC; Salzer WL; McCall CE
    Mol Aspects Med; 1988; 10(6):511-629. PubMed ID: 3076605
    [No Abstract]   [Full Text] [Related]  

  • 34. Subclinical kidney injury incites endotoxin hyperresponsiveness.
    Bolisetty S; Agarwal A
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F41-2. PubMed ID: 17507600
    [No Abstract]   [Full Text] [Related]  

  • 35. Endotoxin-related intracellular pathways: implications for therapeutic intervention.
    Ulevitch RJ; Dunn DL; Fink MP; Taylor CE
    Shock; 1996 Jul; 6(1):1-2. PubMed ID: 8828075
    [No Abstract]   [Full Text] [Related]  

  • 36. The complex challenge of bacteremia and endotoxemia.
    Young LS
    Prog Clin Biol Res; 1988; 272():209-12. PubMed ID: 3293078
    [No Abstract]   [Full Text] [Related]  

  • 37. Interaction of nanoparticles with endotoxin
    Mangini M; Verde A; Boraschi D; Puntes VF; Italiani P; De Luca AC
    Nanotoxicology; 2021 May; 15(4):558-576. PubMed ID: 33784953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin leucoencephalopathy in the telencephalon of the newborn kitten.
    Gilles FH; Leviton A; Kerr CS
    J Neurol Sci; 1976 Feb; 27(2):183-91. PubMed ID: 1249585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endotoxins and mediators--an introduction.
    Young LS
    Prog Clin Biol Res; 1991; 367():1-7. PubMed ID: 1924419
    [No Abstract]   [Full Text] [Related]  

  • 40. Emetic action of bacterial endotoxin in the cat.
    Sugiyama H; Hayama T; Yagasaki O
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):278-81. PubMed ID: 5216486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.